gameChange
Commercial- Indications
- Psychosis
Company intelligence / Profile preview
BehaVR developed a suite of clinically validated digital therapeutics using immersive VR/AR technology to address a range of mental wellness and behavioral conditions. Their solutions have been used in hospital systems for maternal care and are being advanced through partnerships for broader indications such as anxiety disorders and depression. The company’s platform enables clinician oversight, patient-specific care plans, measurable outcomes, and dynamic adaptation based on real-time biometrics. In November 2023, BehaVR merged with Fern Health to form RealizedCare
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BehaVR.